abstract |
The invention relates to use of inhibitors of progression of the cell cycle through the G1/S transition point in the prevention or treatment of Alzheimer's disease. In particular, the invention relates to use of retinoids or retinoid receptor selective ligands, in particular retinoic acid and its salts or derivatives, for treatment or prevention of Alzheimer's disease. |